文献速递血液透析通路慢性静脉疾病

右心房旁路移植治疗透析患者上腔静脉综合征的长期结果

Long Term Results of Bypass Graft to the Right Atrium in the Management of Superior Vena Cava Syndrome in Dialysis Patients.
PubMed 文献 · Ann Vasc Surg · 2021-03-06

回顾性分析2012至2014年5例接受右心房旁路移植的透析患者,其中4例有上臂透析通路严重功能障碍合并上腔静脉综合征,1例股静脉隧道导管患者有上腔静脉闭塞,均不适合下肢通路或腹膜透析。手术技术均成功,1年旁路次级通畅率100%,长期通畅需严格随访和积极腔内干预。

要点

  • 右心房旁路移植可维持或新建透析通路功能。
  • 1年旁路次级通畅率为100%。
  • 长期通畅需严格随访和积极腔内治疗。

核心结论

  • 右心房旁路移植对透析合并上腔静脉闭塞患者可成功维持既有或新建血管通路功能。
  • 长期次级通畅可实现,但需严格随访和积极腔内策略处理通路或旁路移植物病变。

研究设计与样本

  • 回顾性综述5例透析患者,2012至2014年接受右心房旁路移植。
  • 4例有上臂透析通路严重功能障碍及上腔静脉综合征,1例股静脉隧道导管患者有上腔静脉闭塞。
  • 均不适合下肢通路或腹膜透析;3例行左头臂静脉-右心房旁路,2例行头静脉瘘至右心房旁路。

主要发现

  • 所有手术技术成功,维持动静脉瘘功能或允许新建上臂透析移植物。
  • 旁路1年次级通畅率100%。
  • 一例术后14个月内死于腿部脓毒症,另一例死于卒中。
  • 一例16个月良好后复发移植物血栓,经多次干预后31个月移植失败。
  • 两例随访78个月维持旁路通畅,但需多次腔内干预(23次)和开放血管通路手术(4次)维持透析功能。

临床怎么用

  • 对不适合下肢通路或腹膜透析的上腔静脉闭塞透析患者,可考虑右心房旁路移植。
  • 术后需严格随访并积极腔内治疗通路及旁路移植物病变以维持长期通畅。

局限性

  • 回顾性研究,样本量仅5例。
  • 无长期结局数据先前报道,本研究为单中心小样本经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Superior vena cava (SVC) occlusion in dialysis patients is a serious complication that can cause SVC syndrome and vascular access dysfunction. While endovascular therapy has advanced to become the first line of treatment, open surgical treatment may still be needed occasionally. However, no long term outcome data has been previously reported. METHODS: We performed a retrospective review of 5 dialysis patients treated with bypass graft to the right atrium from 2012 to 2014. Four patients had severe dysfunction of their upper arm dialysis access as well as superior vena cava syndrome, and one patient with a femoral tunneled dialysis catheter (TDC) had SVC occlusion. None of the patients were candidates for lower extremity access creation or peritoneal dialysis (PD). Three patients underwent a left brachiocephalic-right atrial bypass and 2 underwent a bypass from the cephalic fistula to the right atrium. RESULTS: All procedures were technically successful and maintained function of the arteriovenous fistulas or allowed creation of a new upper extremity dialysis graft. One-year secondary patency rate of the bypass was 100%. Longer follow up revealed that one patient died of leg sepsis and another one of a stroke within 14 months after the procedure. Another patient did well for 16 months when recurrent graft thrombosis occurred; and ultimately the graft failed after 31 months despite multiple interventions. Two patients maintained bypass graft patency during a follow up of 78 months; however, they underwent multiple endovascular interventions (23) and open vascular access procedures (4) to maintain hemodialysis function. CONCLUSION: Bypass grafts to the right atrium in dialysis patients with SVC occlusion are successful in maintaining function of already existing vascular access or new ones. Long term secondary patency can be achieved but requires strict follow up and a proactive endovascular strategy to treat lesions in the access and or the bypass graft.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Uceda PV, Feldtman RW, Ahn SS, et al. Long Term Results of Bypass Graft to the Right Atrium in the Management of Superior Vena Cava Syndrome in Dialysis Patients. Ann Vasc Surg. 2021. PMID: 33689760. doi:10.1016/j.avsg.2021.01.099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。